EUDA Health Holdings Ltd
Income Statement
| Line Item | FY2023 | FY2022 | FY2021 |
|---|---|---|---|
| Revenue | — | $9.8M | $10.5M |
| Cost of Revenue | — | $6.5M | $6.3M |
| Gross Profit | — | $3.4M | $4.2M |
| Gross Margin | — | 34.1% | 40.3% |
| Operating Expenses | |||
| Research & Development | — | $17.2K | $129.3K |
| SG&A Expense | — | $7.2M | $4.1M |
| Operating Income | — | $-12.1M | $-1.2M |
| Operating Margin | — | -122.5% | -11.6% |
| Interest Expense | — | — | — |
| Pretax Income | — | $-24.9M | $948.5K |
| Income Tax Expense | — | $17.4K | $48.1K |
| Net Income | — | $-24.9M | $864.8K |
| Net Margin | — | -252.9% | 8.2% |
| EPS (Basic) | — | $-2.07 | $0.09 |
| EPS (Diluted) | — | — | — |
| Shares Outstanding (Basic) | 24.8M | 12.0M | 9.3M |
| Shares Outstanding (Diluted) | 24.8M | 12.0M | 9.3M |
| Dividends Per Share | — | — | — |